Inhibitory activity of hibifolin on adenosine deaminase- experimental and molecular modeling study
暂无分享,去创建一个
G. Arun Kumar | C. Sharanya Suresh | P. M. Sandeep | C. Sadasivan | C. Sadasivan | G. A. Kumar | C. Suresh
[1] J. Mallol,et al. Moonlighting Adenosine Deaminase: A Target Protein for Drug Development , 2015, Medicinal research reviews.
[2] P. Ramesh,et al. A NEW FLAVONE METHYL ETHER FROM HELICTERES ISORA , 1995 .
[3] F A Quiocho,et al. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. , 1991, Science.
[4] Takayoshi Kinoshita,et al. A highly potent non-nucleoside adenosine deaminase inhibitor: efficient drug discovery by intentional lead hybridization. , 2004 .
[5] F A Quiocho,et al. Complexes of adenosine deaminase with two potent inhibitors: X-ray structures in four independent molecules at pH of maximum activity. , 1998, Biochemistry.
[6] Ettore Novellino,et al. Exploiting the pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors. , 2009, Journal of medicinal chemistry.
[7] R. Glazer. Adenosine deaminase inhibitors: Their role in chemotherapy and immunosuppression , 2004, Cancer Chemotherapy and Pharmacology.
[8] G. Cristalli,et al. Functional residues at the active site of bovine brain adenosine deaminase , 1997, Biochemistry and molecular biology international.
[9] J. Mallol,et al. Human adenosine deaminase as an allosteric modulator of human A1 adenosine receptor: abolishment of negative cooperativity for [3H](R)‐pia binding to the caudate nucleus , 2008, Journal of neurochemistry.
[10] M. Melzig. Inhibition of Adenosine Deaminase Activity of Aortic Endothelial Cells by Selected Flavonoids , 1996, Planta medica.
[11] F. Ciruela,et al. Adenosine Deaminase Interacts with A1 Adenosine Receptors in Pig Brain Cortical Membranes , 1996, Journal of neurochemistry.
[12] V. Valli,et al. Therapeutic potential for transient inhibition of adenosine deaminase in systemic inflammatory response syndrome , 2003, Critical care medicine.
[13] T. Brady,et al. A purification of adenosine deaminase from the superficial mucosa of calf intestine. , 1962, Biochimica et biophysica acta.
[14] M. Hegen,et al. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. , 1996, Journal of immunology.
[15] B. Mitchell,et al. Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo. , 1980, Blood.
[16] Dong Wan Kim,et al. Isolation and characterization of a novel adenosine deaminase inhibitor, IADA-7, from Bacillus sp. J-89 , 2009 .
[17] N. Pfrogner. Adenosine deaminase from calf spleen. I. Purificiation. , 1967, Archives of biochemistry and biophysics.
[18] T. Kinoshita,et al. Structural basis of compound recognition by adenosine deaminase. , 2005, Biochemistry.
[19] V. Caiolfa,et al. Adenosine deaminase-complexing protein from bovine kidney. Isolation of two distinct subunits. , 1988, The Journal of biological chemistry.
[20] W. L. Jorgensen,et al. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.
[21] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[22] Thomas A. Halgren,et al. Merck molecular force field. IV. conformational energies and geometries for MMFF94 , 1996 .
[23] T. Kinoshita,et al. Crystallization and preliminary analysis of bovine adenosine deaminase. , 1999, Acta crystallographica. Section D, Biological crystallography.
[24] M. Grever,et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. , 2000, Blood.
[25] M. Wargovich,et al. Inhibition of carcinogenesis by tea: the evidence from experimental studies. , 1997, Critical reviews in food science and nutrition.
[26] E. Giblett,et al. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. , 1972, Lancet.